Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

More Training Opportunities

AHCMCC2 - Image - 300x200 - Lab ScenePostdoctoral and Predoctoral Training Opportunities

The multi-disciplinary and collaborative research environment that the Masonic Cancer Center fosters provides unique training opportunities for the next generation of cancer researchers. A number of things characterize and distinguish the training environment here.

Large public research university

The Masonic Cancer Center is located on the campus of one of the largest public universities in the country with a robust research environment. The University of Minnesota ranks among the top 10 public research universities in both NIH funding and federal funding for science and engineering.

Top researchers in a wide variety of research areas
With more than 500 faculty and staff members, the cancer center is home of some of the world's top cancer researchers in:

  • bone marrow transplantation
  • breast cancer
  • bone cancer
  • cancer genetics
  • tobacco research
  • immunology
  • new therapies development
  • pediatric oncology
  • chemoprevention
  • epidemiology

Our collaborative environment
The Masonic Cancer Center, one of 45 NCI-designated comprehensive cancer centers in the U.S., was founded in 1991 and is part of the Academic Health Center, which includes the Medical School, School of Dentistry, School of Nursing, College of Pharmacy, School of Public Health and College of Veterinary Medicine. The center's research partners include the University's Stem Cell Insittute, Center for Immunology, Center for Magnetic Resonance Imaging, and the Institute of Human Genetics; and its clinical research and treatment partners include the University of Minnesota Physicians; University of Minnesota Medical Center, Fairview; and the University of Minnesota Amplatz Children's Hospital.

Life in the Twin Cities
The University is located in Minneapolis and St. Paul, Minnesota, together known as the Twin Cities—the state's major metropolitan area. With a population of nearly three million, the Twin Cities offers the best of urban living. Both cities offer busy downtowns, sophisticated educational and cultural institutions, entertainment and sports, and the always affordable diversions of parks, lakes, and open spaces. For more about life in the Twin Cities, watch a video.

Postdoctoral Fellowship Opportunities

Numerous NIH fellowship opportunities are available in the Masonic Cancer Center and throughout the Academic Health Center for predoctoral and postdoctoral fellows currently training in laboratories of faculty at the University of Minnesota. Candidates not currently working at the U of M can contact training grant directors and faculty preceptors direcly by clicking on the links below to find out about available positions:

Predoctoral Training Opportunities

Opportunities are available for graduate students to obtain rigorous laboratory-based training in the biology of cancer at the Masonic Cancer Center. Research opportunities cover the broad areas of cell metastasis/angiogenesis, immunology and cancer, cancer genetics/etiology, and cancer therapy.

A number of NIH T32 training grants provide financial support and specialized programs of training that will allow graduate students to establish themselves as independent investigators who will pursue research into the etiology and treatment of cancer. In addition, cancer center faculty members are members of a broad array of graduate programs that facilitate training in cancer-related fields.

Training Grants

Graduate Programs

Undergraduate Opportunities


  • Hematology Workforce Training Program (R25)
    Allison Hubel, Ph.D., College of Science and Engineering, and David McKenna, M.D., Department of Laboratory Medicine, have received NIH Research Education Program (R25) funding to develop an individualized training program to offer scholars the opportunity to gain experience in the advanced techniques used to process blood and stem-cell based therapies, the sophisticated assays used for product characterization and post-treatment patient assessment, and to learn the regulatory requirements of cell-based therapies. The intent of this integrated education program in development and clinical practice of cell-based therapies is to be instrumental in countering the decline of blood-based investigators and fostering advances in the treatment of hematological and other disease. The program will offer short-term educational experiences in specific techniques to participants in order to further enable their planned research careers in blood research.
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on March 31, 2016